Skip to main content
. 2019 Aug 30;36(4):382–391. doi: 10.5114/ada.2018.80272

Figure 1.

Figure 1

Maculopapular rash (CTCEA grade 2) in a patient treated with anti-PD-1, located in the neckline, back and shoulders, with onset in the 8th week of treatment